Company performance
Add to research
Current Price
as of Jun 18, 2025$13.33
P/E Ratio
N/A
Market Cap
$276.17M
Description
Add to research
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Metrics
Add to research
Overview
- HQDublin, DU
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerAMRN
- Price$13.33-0.60%
Trading Information
- Market cap$276.17M
- Float99.58%
- Average Daily Volume (1m)98,505
- Average Daily Volume (3m)409,362
- EPS-$4.27
Company
- Revenue$214.21M
- Rev growth (1yr)-25.33%
- Net income-$15.76M
- Gross margin58.07%
- EBITDA margin-38.14%
- EBITDA-$16.09M
- EV-$88.89M
- EV/Revenue-0.41
- P/EN/A
- P/S1.29
- P/B0.58
- Debt/Equity1.68
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset